Ginkgo biloba composition, method to prepare the same and uses thereof
AssigneeShanghai Xingling Sci. & Tech. Pharmaceutical Co., Ltd.
InventorsDe Long Xie, Ning Wang, Qi Gao, Guo An Zhang, Bao Ping Shao, Xiao Wu Jin, Xin Sheng Huang
Life of this patent
Estimating the term…
Abstract
This invention provides different compositions extracted from Ginkgo biloba leaves. Said compositions comprise new active components. This invention also provides a method of preparation of the compositions and individual components of said compositions. Finally, this invention provides various uses of this composition.
Claims16
A method for reducing the usage of nitroglycerin in a subject in need thereof, comprising administering to the subject an effective amount of a composition comprising:
- (a) about 44% to about 78% flavonoids;
- (b) about 2.5% to about 10% ginkgolides selected from ginkgolide A, B, C, J or a combination thereof;
- (c) about 2.5% to about 10% bilobalide;
- and
- (d) about 0.1 ppm to about 5 ppm of ginkgolic acids.
A method for reducing the usage of nitroglycerin in a subject in need thereof comprising administering to the subject an effective amount of the composition comprising:
- (a) not less than 44% flavonoids comprising flavonol glycosides;
- (b) not less than 6% lactones comprising ginkgolides selected from ginkgolide A, B, C, J or a combination thereof and bilobalide;
- and
- (c) about 0.1 ppm to about 5 ppm ginkgolic acids.
A method for reducing the usage of nitroglycerin in a subject in need thereof comprising administering to the subject an effective amount of a pharmaceutical composition comprising:
- (a) about 44 % to about 78% flavonoids;
- (b) about 2.5% to about 10% ginkgolides selected from ginkgolide A, B, C, J or a combination thereof;
- (c) about 2.5% to about 10% bilobalide;
- (d) about 0.1 ppm to about 5 ppm of ginkgolic acids;
- and
- (e) a pharmaceutically acceptable carrier.
A method for reducing the usage of nitroglycerin in a subject in need thereof comprising administering to the subject an effective amount of a pharmaceutical composition comprising:
- (a) not less than 44% flavonoids comprising flavonol glycosides;
- (b) not less than 6% lactones comprising ginkgolides selected from ginkgolide A, B, C, J or a combination thereof and bilobalide;
- (c) about 0.1 ppm to about 5 ppm ginkgolic acids;
- and
- (d) a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.